Related references
Note: Only part of the references are listed.Treatment With Y-90/Lu-177-DOTATOC in Patients With Metastatic Adrenocortical Carcinoma Expressing Somatostatin Receptors
Salvatore Grisanti et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2020)
Interplay between glucocorticoids and tumor-infiltrating lymphocytes on the prognosis of adrenocortical carcinoma
Laura-Sophie Landwehr et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2020)
Early Postoperative Circulating miR-483-5p Is a Prognosis Marker for Adrenocortical Cancer
Maurine Oreglia et al.
CANCERS (2020)
Adrenocortical carcinoma - towards genomics guided clinical care
Joakim Crona et al.
NATURE REVIEWS ENDOCRINOLOGY (2019)
Phase II clinical trial of pembrolizumab efficacy and safety in advanced adrenocortical carcinoma
Mouhammed Amir Habra et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
Antineoplastic Effect of a Combined Mitotane Treatment/Ionizing Radiation in Adrenocortical Carcinoma: A Preclinical Study
Lidia Cerquetti et al.
CANCERS (2019)
Copenhagen Prospective Personalized Oncology (CoPPO)-Clinical Utility of Using Molecular Profiling to Select Patients to Phase I Trials
Ida Viller Tuxen et al.
CLINICAL CANCER RESEARCH (2019)
Phase I Study of ATR Inhibitor M6620 in Combination With Topotecan in Patients With Advanced Solid Tumors
Anish Thomas et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Targeted Therapy for Advanced Solid Tumors on the Basis of Molecular Profiles: Results From MyPathway, an Open-Label, Phase IIa Multiple Basket Study
John D. Hainsworth et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
European Society of Endocrinology Clinical Practice Guidelines on the management of adrenocortical carcinoma in adults, in collaboration with the European Network for the Study of Adrenal Tumors
Martin Fassnacht et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2018)
Synergistic combination of flavopiridol and carfilzomib targets commonly dysregulated pathways in adrenocortical carcinoma and has biomarkers of response
Naris Nilubol et al.
Oncotarget (2018)
Avelumab in patients with previously treated metastatic adrenocortical carcinoma: phase 1b results from the JAVELIN solid tumor trial
Christophe Le Tourneau et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2018)
Palbociclib inhibits proliferation of human adrenocortical tumor cells
Chiara Fiorentini et al.
ENDOCRINE (2018)
Gemcitabine-Based Chemotherapy in Adrenocortical Carcinoma: A Multicenter Study of Efficacy and Predictive Factors
Judith E. K. Henning et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2017)
The efficacy of radiation therapy in adrenocortical carcinoma A propensity score analysis of a population-based study
You Luo et al.
MEDICINE (2017)
Olaparib for Metastatic Breast Cancer in Patients with a Germline BRCA Mutation
Mark Robson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
P53/Rb inhibition induces metastatic adrenocortical carcinomas in a preclinical transgenic model
M. Batisse-Lignier et al.
ONCOGENE (2017)
Analysis of 100,000 human cancer genomes reveals the landscape of tumor mutational burden
Zachary R. Chalmers et al.
GENOME MEDICINE (2017)
A hypothesis-driven approach identifies CDK4 and CDK6 inhibitors as candidate drugs for treatments of adrenocortical carcinomas
Djihad Hadjadj et al.
AGING-US (2017)
Future directions in the diagnosis and medical treatment of adrenocortical carcinoma
S. G. Creemers et al.
ENDOCRINE-RELATED CANCER (2016)
Comprehensive Pan-Genomic Characterization of Adrenocortical Carcinoma
Siyuan Zheng et al.
CANCER CELL (2016)
Identification of Niclosamide as a Novel Anticancer Agent for Adrenocortical Carcinoma
Kei Satoh et al.
CLINICAL CANCER RESEARCH (2016)
EZH2 is overexpressed in adrenocortical carcinoma and is associated with disease progression
Coralie Drelon et al.
HUMAN MOLECULAR GENETICS (2016)
Actual 10-Year Survivors Following Resection of Adrenocortical Carcinoma
Thuy B. Tran et al.
JOURNAL OF SURGICAL ONCOLOGY (2016)
Activity of Selumetinib in Neurofibromatosis Type 1-Related Plexiform Neurofibromas
Eva Dombi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
ATRX loss promotes tumor growth and impairs nonhomologous end joining DNA repair in glioma
Carl Koschmann et al.
SCIENCE TRANSLATIONAL MEDICINE (2016)
Notch1 pathway in adrenocortical carcinomas: correlations with clinical outcome
Cristina L. Ronchi et al.
ENDOCRINE-RELATED CANCER (2015)
Prevalence and Functional Consequence of TP53 Mutations in Pediatric Adrenocortical Carcinoma: A Children's Oncology Group Study
Jonathan D. Wasserman et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Linsitinib (OSI-906) versus placebo for patients with locally advanced or metastatic adrenocortical carcinoma: a double-blind, randomised, phase 3 study
Martin Fassnacht et al.
LANCET ONCOLOGY (2015)
PD-1 Blockade in Tumors with Mismatch-Repair Deficiency
D. T. Le et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
DNA-Repair Defects and Olaparib in Metastatic Prostate Cancer
J. Mateo et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Alternative lengthening of telomeres renders cancer cells hypersensitive to ATR inhibitors
Rachel Litman Flynn et al.
SCIENCE (2015)
ATR Inhibitors VE-821 and VX-970 Sensitize Cancer Cells to Topoisomerase I Inhibitors by Disabling DNA Replication Initiation and Fork Elongation Responses
Rozenn Josse et al.
CANCER RESEARCH (2014)
Integrated genomic characterization of adrenocortical carcinoma
Guillaume Assie et al.
NATURE GENETICS (2014)
Serum miR-483-5p and miR-195 are predictive of recurrence risk in adrenocortical cancer patients
O. Chabre et al.
ENDOCRINE-RELATED CANCER (2013)
Adrenocortical carcinoma: A population-based study on incidence and survival in the Netherlands since 1993
Thomas M. A. Kerkhofs et al.
EUROPEAN JOURNAL OF CANCER (2013)
Identification of a CpG Island Methylator Phenotype in Adrenocortical Carcinomas
Olivia Barreau et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2013)
The Role of Surgery in the Management of Recurrent Adrenocortical Carcinoma
Ilknur Erdogan et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2013)
Prevalence of Germline TP53 Mutations in a Prospective Series of Unselected Patients with Adrenocortical Carcinoma
Victoria M. Raymond et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2013)
Adrenocortical Carcinoma Is a Lynch Syndrome-Associated Cancer
Victoria M. Raymond et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Mutational heterogeneity in cancer and the search for new cancer-associated genes
Michael S. Lawrence et al.
NATURE (2013)
Resection of Adrenocortical Carcinoma Liver Metastasis: Is it Justified?
Sebastien Gaujoux et al.
ANNALS OF SURGICAL ONCOLOGY (2012)
Upregulated JAG1 Enhances Cell Proliferation in Adrenocortical Carcinoma
Derek P. Simon et al.
CLINICAL CANCER RESEARCH (2012)
Adrenal involvement in MEN1. Analysis of 715 cases from the Groupe d'e ' tude des Tumeurs Endocrines database
B. Gatta-Cherifi et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2012)
Quantitative High-Throughput Drug Screening Identifies Novel Classes of Drugs with Anticancer Activity in Thyroid Cancer Cells: Opportunities for Repurposing
Lisa Zhang et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
A Large Family with Carney Complex Caused by the S147G PRKAR1A Mutation Shows a Unique Spectrum of Disease Including Adrenocortical Cancer
Joao Anselmo et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
Carney Complex with Adrenal Cortical Carcinoma
Emilie Morin et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
TP53 Germline Mutations in Adult Patients with Adrenocortical Carcinoma
Leonie J. M. Herrmann et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
Operative management for recurrent and metastatic adrenocortical carcinoma
Nicole M. Datrice et al.
JOURNAL OF SURGICAL ONCOLOGY (2012)
Four clinically utilized drugs were identified and validated for treatment of adrenocortical cancer using quantitative high-throughput screening
Naris Nilubol et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2012)
Absolute quantification of somatic DNA alterations in human cancer
Scott L. Carter et al.
NATURE BIOTECHNOLOGY (2012)
Combination Chemotherapy in Advanced Adrenocortical Carcinoma
Martin Fassnacht et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Olaparib Maintenance Therapy in Platinum-Sensitive Relapsed Ovarian Cancer
Jonathan Ledermann et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Pulmonary Resection for Metastatic Adrenocortical Carcinoma: The National Cancer Institute Experience
Clinton D. Kemp et al.
ANNALS OF THORACIC SURGERY (2011)
MicroRNA Profiling of Adrenocortical Tumors Reveals miR-483 as a Marker of Malignancy
Erin E. Patterson et al.
CANCER (2011)
Beckwith-Wiedemann syndrome
Rosanna Weksberg et al.
EUROPEAN JOURNAL OF HUMAN GENETICS (2010)
Improved Survival in Patients with Stage II Adrenocortical Carcinoma Followed Up Prospectively by Specialized Centers
Martin Fassnacht et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2010)
Pathogenesis of adrenocortical cancer
Jerome Bertherat et al.
BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM (2009)
Limited Prognostic Value of the 2004 International Union Against Cancer Staging Classification for Adrenocortical Carcinomas
Martin Fassnacht et al.
CANCER (2009)
miR-195 and miR-483-5p Identified as Predictors of Poor Prognosis in Adrenocortical Cancer
Patsy Siok Hwa Soon et al.
CLINICAL CANCER RESEARCH (2009)
Gene Expression Profiling Reveals a New Classification of Adrenocortical Tumors and Identifies Molecular Predictors of Malignancy and Survival
Aurelien de Reynies et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Model-based clustering of DNA methylation array data: a recursive-partitioning algorithm for high-dimensional data arising as a mixture of beta distributions
E. Andres Houseman et al.
BMC BIOINFORMATICS (2008)
Adrenocortical Carcinoma in the United States Treatment Utilization and Prognostic Factors
Karl Y. Bilimoria et al.
CANCER (2008)
Mitotane increases the radiotherapy inhibitory effect and induces G2-arrest in combined treatment on both H295R and SW13 adrenocortical cell line
L. Cerquetti et al.
ENDOCRINE-RELATED CANCER (2008)
Response to mitotane predicts outcome in patients with recurrent adrenal cortical carcinoma
Ricardo J. Gonzalez et al.
SURGERY (2007)
Clinical and biological features in the prognosis of adrenocortical cancer: Poor outcome of cortisol-secreting tumors in a series of 202 consecutive patients
Gwenaelle Abiven et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
Constitutional aneuploidy and cancer predisposition caused by biallelic mutations in BUB1B
S Hanks et al.
NATURE GENETICS (2004)
Hereditary early-onset Parkinson's disease caused by mutations in PINK1
EM Valente et al.
SCIENCE (2004)
Proteasome inhibitors potentiate leukemic cell apoptosis induced by the cyclin-dependent kinase inhibitor flavopiridol through a SAPK/JNK- and NF-κB-dependent process
Y Dai et al.
ONCOGENE (2003)
Radiofrequency ablation of adrenal tumors and adrenocortical carcinoma metastases
BJ Wood et al.
CANCER (2003)
Adrenocortical carcinoma: Diagnosis, evaluation and treatment
L Ng et al.
JOURNAL OF UROLOGY (2003)
Adrenocortical carcinomas: Surgical trends and results of a 253-patient series from the French Association of Endocrine Surgeons study group
P Icard et al.
WORLD JOURNAL OF SURGERY (2001)
Share Paper
